CANDYCE BROWN: Open Payments
NPI 1598227779 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,289 in 175 payments from 18 companies in 2025. Trend: 2023 $2,390 · 2024 $3,184 · 2025 $3,289
Food & beverage: $3,289
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $604 |
| ABBVIE INC. | 29 | $458 |
| Alkermes, Inc. | 19 | $361 |
| Axsome Therapeutics, Inc. | 15 | $269 |
| Janssen Pharmaceuticals, Inc | 6 | $218 |
| Teva Pharmaceuticals USA, Inc. | 14 | $190 |
| Corium, LLC | 11 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $177 |
| Neurocrine BioSciences, Inc. | 9 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $130 |
Products named: REXULTI, VRAYLAR, Auvelity, ARISTADA, Azstarys, CAPLYTA, INGREZZA, ZURZUVAE.
Industry payments across LA — which companies pay providers there.
